<DOC>
	<DOCNO>NCT02909062</DOCNO>
	<brief_summary>Electronic activity monitoring ( EAM ) device wearable electronic device monitor functional activity provide personal feedback activity progression . This study aim determine EAM provide objective , assessment patient functional activity . The study also examine change functional activity experience patient first cycle chemotherapy . Another objective study see baseline functional activity change functional activity occur first cycle chemotherapy use predict patient tolerability subsequent cycle chemotherapy .</brief_summary>
	<brief_title>Beyond Performance Status : Electronic Activity Monitoring Assess Functional Activity Patients With Gastrointestinal Malignancy During Chemotherapy .</brief_title>
	<detailed_description />
	<mesh_term>Gastrointestinal Neoplasms</mesh_term>
	<criteria>Clinical diagnosis gastrointestinal malignancy . Age â‰¥ 18 year Planned receive systemic chemotherapy , either adjuvant chemotherapy , neoadjuvant chemotherapy , new line chemotherapy set advanced disease . Restricted mobility define dependence anytime use walker wheelchair past three month . Refusing systemic chemotherapy . Concurrent radiotherapy chemotherapy Starting chemotherapy 6 day early time study consent ( except study participant fulfill condition state section 6.0 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Electronic Activity Monitoring ( EAM )</keyword>
	<keyword>16-493</keyword>
</DOC>